Annovis Bio, Inc.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's di…
Biotechnology
US, Berwyn [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Annovis Bio, Inc. has no acquisition track records yet.
M&A Deals · History
Annovis Bio, Inc. has no acquisition track records yet.